Skip to content

Lung Cancer Blog

Everything about lung cancer is here.

Menu
  • Home
  • About Us
  • Lung Cancer
    • Lung Cancer News
    • Causes of Lung Cancer
    • Lung Cancer Symptoms
    • Types of Lung Cancer
    • Stages of Lung Cancer
    • Lung Cancer Treatment
    • Lung Cancer Drugs
    • Lung Cancer In Ayurveda
    • Chinese Herbs For Lung Cancer
  • Researches
  • Studies
  • Stories
  • Sitemap
  • Contact Us
Menu
lung | Lung Cancer

Tumor Treating Fields to Improve Survival Benefit in Lung Cancer

Posted on September 11, 2023
Post Views: 332

lung | Lung CancerTumor Treating Fields (TTFields) are electric fields that disrupt processes which are critical for the survival of cancer cells. This leads to immunogenic cell death and enhanced antitumor immune response. The use of Tumor treating fields with standard care therapies could lead to a clinically meaningful improvement in survival of patients with metastatic non-small cell lung cancer, according to data from a phase 3 trial. The results are from the LUNAR trial published in The Lancet Oncology.

In the phase 3 trial, the patients who received TTFields therapy and standard therapy had a 26% lower death risk when compared with patients with standard therapy alone. Median overall survival for patients in this trial was 13.2 months with TTFields plus standard care in comparison with 9.9 months with standard care only. The one and three-year overall survival rates were 53% and 18% respectively with addition of TTFields, compared to 42% and 7% in the standard of care alone. Also, there was no significant difference in progression-free survival or overall response rate between the treatment arms. Serious adverse events of any cause were 53% in TTF arm and 38% in standard therapy-alone arm.

“The overall survival benefit with TTFields [tumor-treating fields] therapy occurred without exacerbating the toxicities associated with systemic therapies,” the researchers wrote. “These pivotal efficacy and safety data suggest that TTFields therapy should be considered as a treatment option to manage the disease in this setting.”

This research was supported by Novocure. Novocure is going to participate in 2023 World Conference on Lung Cancer and will exhibit several posters exploring the use of TTFields therapy in lung cancer treatment including a new post-hoc analysis of data from the above discussed LUNAR trial in metastatic non-small cell lung cancer.

The information shared in this blog is for educational purposes only.

Subscribe to our newsletter or follow us on Facebook or Twitter today and never miss out an update!

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Tumblr (Opens in new window) Tumblr
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Telegram (Opens in new window) Telegram

Like this:

Like Loading...

Subscribe Us

Popular Articles

  • Lung Cancer Treatment in Ayurveda (7,322)
  • Lung Cancer: Symptoms and Treatment (5,655)
  • What is Non-Small-Cell Lung Cancer? (5,551)

Recent Comments

  • Lung Cancer on New Study To Help Advance Research In Lung Cancer
  • Laurie B Grimes on New Study To Help Advance Research In Lung Cancer
  • Lung Cancer on Asbestos and Lung Cancer – What’s The Link?

Recent Articles

  • Predicting Lung Cancer Risk with AI based Deep Learning Model May 26, 2025
  • FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC May 19, 2025
  • Heart-Sparing Technique in Lung Cancer Radiotherapy May 12, 2025
  • Origins of Common Lung Cancer Linked to Smoking Discovered May 5, 2025
  • Lung Cancer Screening Is Beneficial For Non-Smokers As Well April 28, 2025

Lung Cancer Blog

Lung Cancer Blog provides all lung cancer related information for educational purposes.

Disclaimer

Some post may contain affiliate links, purchasing that product not going to cost extra but by your purchase Lung Cancer will get some little commission and that amount will help in surviving this website. So, please don’t hesitate to buy from these affiliate links.

Contact Us

If you have any query or suggestions about our blog, please feel free to email us at  lungcancersymptomsx@gmail.com.

Copyright © 2012 - 2025 Lung Cancer Blog. Wordpress by Vipasha.
  • Privacy Policy
  • About Us
  • Sitemap
  • Contact Us
%d